S Yagel

No ORCID on file · 1 paper in corpus
observational 1996
European Journal of Obstetrics & Gynecology and Reproductive Biology ·doi:10.1016/0301-2115(95)02515-4

BACKGROUND: Tamoxifen is known to exert agonist estrogenic effects on the uterus. Its use in postmenopausal women has also been associated with various endometrial and uterine abnormalities that can be detected by endovaginal sonography. O…